Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction
Status:
Recruiting
Trial end date:
2024-06-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of Tranexamic Acid Oral Solution 5% in
patients treated with direct oral anticoagulants or vitamin K antagonists and undergoing a
single or multiple tooth extraction.